Research and Achievements

Fiscal Year2017

Achievements for Fiscal Year 2017

    1. Yoshii Y, Shimizu K, Morozumi M, Chiba N, Ubukata K, Uruga H, Hanada S, Wakui H, Minagawa S, Hara H, Numata T, Saito S, Araya J, Nakayama K, Kishi K, Kuwano K. Detection of pathogens by real-time PCR in adult patients with acute exacerbation of bronchial asthma. BMC Pulmonary Medicine. 2017; 17:150.
    2. Toyofuku M, Morozumi M, Hida M, Satoh Y, Sakata H, Shiro H, Ubukata K, Murata M, Iwata S. Effects of intrapartum antibiotic prophylaxis on neonatal acquisition of Group B streptococci. J Pediatrics. 2017; 190:169-173.
    3. Nishikawa-Nakamura N, Okada T, Nishimura K, Iwai T, Ubukata K, Iwata S, Iwai A. An infant with concurrent serotype 6C invasive pneumococcal disease and infectious mononucleosis. J Infect Chemother. 2017; 23:785-787.
    4. Chiba N, Murayama SY, Morozumi M, Iwata S, Ubukata K.　Genome Evolution to Penicillin Resistance in Serotype 3 Streptococcus pneumoniae by Capsular Switching. Antimicrob Agents Chemother. 2017; 61:69
    5. Morozumi M, Okada T, Tajima T, Ubukata K, Iwata S. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae. Int J Antimicrob Agents. 2017; 50: 255-257.
    6. Sakata H, Adachi Y, Morozumi M, Ubukata K. Invasive Haemophilus influenzae infections in children in Kamikawa subprefecture, Hokkaido, Japan, 2006-2015: The effectiveness of H. influenzae type b vaccine. J Infect Chemother. 2017; 23: 459-462.
    7. Ebara Y, Morozumi M, Sato M, Moritoki N, Toyofuku M, Takata M, Murata M, Ubukata K, Iwata S. Enhancement of bactericidal activity against group B streptococci with reduced penicillin susceptibility by uptake of gentamicin into cells resulting from combination with β-lactam antibiotics. J Infect Chemother. 2017;23 :312-318.

  1. ★★★Yoshii Y, Shimizu K, Morozumi M, Chiba N, Ubukata K, Uruga H, Hanada S, Wakui H, Minagawa S, Hara H, Numata T, Saito S, Araya J, Nakayama K, Kishi K, Kuwano K. Detection of pathogens by real-time PCR in adult patients with acute exacerbation of bronchial asthma. BMC Pulmonary Medicine. 2017; 17:150.
  2. ★★★Toyofuku M, Morozumi M, Hida M, Satoh Y, Sakata H, Shiro H, Ubukata K, Murata M, Iwata S. Effects of intrapartum antibiotic prophylaxis on neonatal acquisition of Group B streptococci. J Pediatrics. 2017; 190:169-173.
  3. ★★★Nishikawa-Nakamura N, Okada T, Nishimura K, Iwai T, Ubukata K, Iwata S, Iwai A. An infant with concurrent serotype 6C invasive pneumococcal disease and infectious mononucleosis. J Infect Chemother. 2017; 23:785-787.
  4. ★★★Chiba N, Murayama SY, Morozumi M, Iwata S, Ubukata K.　Genome Evolution to Penicillin Resistance in Serotype 3 Streptococcus pneumoniae by Capsular Switching. Antimicrob Agents Chemother. 2017; 61:69
  5. ★★★Morozumi M, Okada T, Tajima T, Ubukata K, Iwata S. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae. Int J Antimicrob Agents. 2017; 50: 255-257.
  6. ★★★Sakata H, Adachi Y, Morozumi M, Ubukata K. Invasive Haemophilus influenzae infections in children in Kamikawa subprefecture, Hokkaido, Japan, 2006-2015: The effectiveness of H. influenzae type b vaccine. J Infect Chemother. 2017; 23: 459-462.
  7. ★★★Ebara Y, Morozumi M, Sato M, Moritoki N, Toyofuku M, Takata M, Murata M, Ubukata K, Iwata S. Enhancement of bactericidal activity against group B streptococci with reduced penicillin susceptibility by uptake of gentamicin into cells resulting from combination with β-lactam antibiotics. J Infect Chemother. 2017;23 :312-318.
  8. Lodh N, Mikita K, Bosompem KM, Anyan WK, Quartey JK, Otchere J, Shiff CJ. Point of care diagnosis of multiple schistosome parasites: Species-specific DNA detection in urine by loop-mediated isothermal amplification (LAMP). Acta Trop. 2017.; 173: 125-9
  9. Tamura S, Maeda T, Misawa K, Osa M, Hamamoto T, Yuki A, Imai K, Mikita K, Morichika K, Kawana A, Matsumoto H, Nonoyama S. Development of a highly resolved loop-mediated isothermal amplification method to detect the N526K ftsI mutation of β-lactamase-negative ampicillin-resistant Haemophilus influenzae. J Microbiol Methods. 2017.; 141: 108-14

Return to the List of
Research and Achievements